Cargando…

A Reversible Shift of Driver Dependence from EGFR to Notch1 in Non-Small Cell Lung Cancer as a Cause of Resistance to Tyrosine Kinase Inhibitors

SIMPLE SUMMARY: Notch1 and EGFR are two surface receptors activating different cellular processes in cancer cells. EGFR, harboring activating mutations, drives unlimited cell proliferation in non-small cell lung cancer (NSCLC), and treatment of tumors with tyrosine kinase inhibitors (TKIs) results i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iommelli, Francesca, De Rosa, Viviana, Terlizzi, Cristina, Fonti, Rosa, Camerlingo, Rosa, Stoppelli, Maria Patrizia, Stewart, C. Allison, Byers, Lauren Averett, Piwnica-Worms, David, Del Vecchio, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122511/ https://www.ncbi.nlm.nih.gov/pubmed/33922104 http://dx.doi.org/10.3390/cancers13092022

Ejemplares similares

Early (18)F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
por: De Rosa, Viviana, et al.
Publicado: (2016)

Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC
por: De Rosa, Viviana, et al.
Publicado: (2021)

Coordinate Modulation of Glycolytic Enzymes and OXPHOS by Imatinib in BCR-ABL Driven Chronic Myelogenous Leukemia Cells
por: De Rosa, Viviana, et al.
Publicado: (2019)

Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy
por: De Rosa, Viviana, et al.
Publicado: (2021)

Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins
por: Monti, Marcello, et al.
Publicado: (2018)

ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors
por: Terlizzi, Cristina, et al.
Publicado: (2023)

Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells
por: Monti, Marcello, et al.
Publicado: (2017)

What molecular imaging of cancer patients can teach us about COVID-19
por: Del Vecchio, Silvana, et al.
Publicado: (2022)

PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients
por: Pellegrino, Sara, et al.
Publicado: (2021)

Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
por: Fonti, Rosa, et al.
Publicado: (2020)

Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides
por: Belli, Stefania, et al.
Publicado: (2020)

ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer
por: Della Corte, Carminia Maria, et al.
Publicado: (2018)

Casein Kinase 1 Functions as both Penultimate and Ultimate Kinase in Regulating Cdc25A Destruction
por: Honaker, Yuchi, et al.
Publicado: (2010)

Evaluation of metabolic response with (18)F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors
por: Segreto, Sabrina, et al.
Publicado: (2017)

A Fluorescence-Coupled Assay for Gamma Aminobutyric Acid (GABA) Reveals Metabolic Stress-Induced Modulation of GABA Content in Neuroendocrine Cancer
por: Ippolito, Joseph E., et al.
Publicado: (2014)

Multi-Modal Multi-Spectral Intravital Microscopic Imaging of Signaling Dynamics in Real-Time during Tumor–Immune Interactions
por: Liu, Tracy W., et al.
Publicado: (2021)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Heterogeneity of Glycolytic Phenotype Determined by (18)F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer
por: Pellegrino, Sara, et al.
Publicado: (2023)

A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma
por: Goiffon, Reece J., et al.
Publicado: (2015)

Multi-Modal Multi-Spectral Intravital Macroscopic Imaging of Signaling Dynamics in Real Time during Tumor–Immune Interactions
por: Liu, Tracy W., et al.
Publicado: (2021)

NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
por: Diluvio, Giulia, et al.
Publicado: (2018)

EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice
por: Prada, Patricia O., et al.
Publicado: (2009)

The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
por: Gallo, Marianna, et al.
Publicado: (2022)

Notch as a Driver of Gastric Epithelial Cell Proliferation
por: Demitrack, Elise S., et al.
Publicado: (2017)

Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast
por: Sinha, Vidya C., et al.
Publicado: (2021)

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma
por: Ni, Wei, et al.
Publicado: (2021)

Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems
por: Dothager, Robin S., et al.
Publicado: (2010)

Flavour processing in semantic dementia
por: Piwnica-Worms, Katherine E., et al.
Publicado: (2010)

Human Cytomegalovirus Protein pUL117 Targets the Mini-Chromosome Maintenance Complex and Suppresses Cellular DNA Synthesis
por: Qian, Zhikang, et al.
Publicado: (2010)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
por: Huang, Lihua, et al.
Publicado: (2015)

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
por: Mishani, Eyal, et al.
Publicado: (2008)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers
por: Cardnell, Robert J., et al.
Publicado: (2019)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit
por: Nakajima, Hiroyuki, et al.
Publicado: (2008)

Contributions Made by CDC25 Phosphatases to Proliferation of Intestinal Epithelial Stem and Progenitor Cells
por: Lee, Gwanghee, et al.
Publicado: (2011)

Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
por: Origanti, Sofia, et al.
Publicado: (2012)

Spatial and Temporal Confined Photothermolysis of Cancer Cells Mediated by Hollow Gold Nanospheres Targeted to Epidermal Growth Factor Receptors
por: Ku, Geng, et al.
Publicado: (2018)

RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer
por: Wang, Chunyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_briql5k2jgpvot7a0j6b0j4ard